During the past decade, Thomas Jefferson University, Sidney Kimmel Cancer Center; Clinical Research Organization conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Thomas Jefferson University, Sidney Kimmel Cancer Center; Clinical Research Organization" #1 sponsor was "Bristol-Myers Squibb" with 2 trials, followed by "Gilead Sciences" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Artios Pharma Ltd" with 1 trials sponsored and "Regeneron Pharmaceuticals" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Thomas Jefferson University, Sidney Kimmel Cancer Center; Clinical Research Organization" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Kartos Therapeutics, Inc." with 1 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Thomas Jefferson University, Sidney Kimmel Cancer Center; Clinical Research Organization" are "Acute Myeloid Leukemia" (2 trials), "Advanced Cancer" (1 trials), "Cancer of the Prostate" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Colorectal Neoplasms" (1 trials). Many other conditions were trialed in "Thomas Jefferson University, Sidney Kimmel Cancer Center; Clinical Research Organization" in a lesser frequency.

Most popular intervention types in "Thomas Jefferson University, Sidney Kimmel Cancer Center; Clinical Research Organization" are "Drug" (9 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Azacitidine" (2 trials), "Magrolimab" (2 trials), "18F-DCFPyL" (1 trials) and "ART0380" (1 trials). Other intervention names were less common.

The vast majority of trials in "Thomas Jefferson University, Sidney Kimmel Cancer Center; Clinical Research Organization" are 7 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Thomas Jefferson University, Sidney Kimmel Cancer Center; Clinical Research Organization". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Thomas Jefferson University, Sidney Kimmel Cancer Center; Clinical Research Organization, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Thomas Jefferson University, Sidney Kimmel Cancer Center; Clinical Research Organization, 4 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".